Coccidioidomycosis: A Reemerging Infectious Disease

Emerging Infectious Diseases

Volumn 2, Issue 3, 1996, Pages 192-199

  Kirkland, Theo N ^a,b,c   Fierer, Joshua ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Department of Pathology and Medicine ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT;

COCCIDIOIDES; COCCIDIOIDOMYCOSIS; EPIDEMIC; GROWTH, DEVELOPMENT AND AGING; HUMAN; INCIDENCE; PATHOGENICITY; REVIEW; UNITED STATES;

ANTIFUNGAL AGENTS; COCCIDIOIDES; COCCIDIOIDOMYCOSIS; DISEASE OUTBREAKS; HUMANS; INCIDENCE; SOUTHWESTERN UNITED STATES;

EID: 0030184730     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0203.960305     Document Type: Article

References (55)

1. Morse SS. Factors in the emergence of infectious diseases. Emerging Infectious Diseases 1995;1:7-15.
2. Deresinski SC. History of coccidioidomycosis: "dust to dust." In: Stevens DA, editor. Coccidioidomycosis. New York: Plenum, 1980:1-20.
3. Harrison WR, Merbs CF, Leathers CR. Evidence of coccidioidomycosis in the skeleton of an ancient Arizona Indian. J Infect Dis 1991;164:436-7.
4. Cole GT, Sun SH. Arthroconidium-spherule-endospore transformation in Coccidioides immitis. In: Szaniszlo PJ, Harris L, editors. Fungal dimorphism: with emphasis on fungi pathogenic for humans. New York: Plenum, 1985:281-333.
5. Pappagianis D. Epidemiology of coccidioidomycosis. Curr Top Med Mycol 1988;2:199-238.
6. Converse JL. Effect of surface active agents on endosporulation of Coccidioides immitis in a chemically defined medium. J Bacteriol 1957;74:106-7.
7. Kamel SM, Wheat LJ, Garten ML, Bartlett MS, Tansey MR, Tewari RP. Production and characterization of murine monoclonal antibodies to Histoplasma capsulatum yeast cell antigens. Infect Immun 1989;57:896-901.
8. Lacy GH, Swatek FE. Soil ecology of Coccidioides immitis at Amerindian middens in California. Appl Microbiol 1974;27:379-88.
9. Maddy KT. The geographic distribution of Coccidioides immitis and possible ecologic implications. Ariz Med 1958;15:178-88.
10. Smith CE, Beard RR, Rosenberger HG, Whiting EG. Effect of season and dust control on coccidioidomycosis. JAMA 1946;132:833-8.
11. Pappagianis D, Einstein H. Tempest from Tehachapi takes toll or Coccidioides conveyed aloft and afar. West J Med 1978;129:527-30.
12. CDC. Coccidioidomycosis following the Northridge earthquake - California, 1994. MMWR 1994;43:194-5.
13. Johnson WM. Occupational factors in coccidioidomycosis. J Occup Med 1981;23:367-74.
14. Werner SB, Pappagianis D. Coccidioidomyoosis in northern California - an outbreak among archeology students near Red Bluff. Calif Med 1973;119:16-20.
15. Smith CE, Beard RR, Whiting EG, Rosenberg HG. Varieties of coccidioidal infection in relation to the epidemiology and control of diseases. Am J Public Health 1946;36:1394-1402.
16. Galgiani JN. Coccidioidomycosis. West J Med 1993;159:153-71.
17. Smith CE. Epidemiology of acute coccidioidomycosis with erythema nodosum ("San Joaquin" or "Valley Fever"). Am J Public Health 1940;30:600-11.
18. Baker EJ, Hawkins JA, Waskow EA. Surgery for coccidioidomycosis in 52 diabetic patients with special reference to related immunologic factors. J Thorac Cardiovasc Surg 1978;75:680-7.
19. Smith CE, Beard RR, Saito MT. Pathogenesis of coccidioidomycosis with special reference to pulmonary cavitation. Ann Intern Med 1948;29:623-55.
20. Williams PL, Sable DL, Mendez P, Smyth LT. Symptomatic coccidioidomycosis following a severe natural dust storm - an outbreak at the Naval Air Station, Lemoore, Calif. Chest 1979;76:566-70.
21. Kirkland TN, Fierer J. Inbred mouse strains differ in resistance to lethal Coccidiodes immitis infection. Infect Immun 1983;40:912.
22. Kirkland TN, Fierer J. Genetic control of resistance to Coccidioides immitis: a single gene that is expressed in spleen cells determines resistance. J Immunol 1985;135:548-52.
23. Cox RA, Kennell W. Suppression of T-lymphocyte response by Coccidioides immitis antigen. Infect Immun 1988;56:1424-9.
24. Wack EE, Ampel NM, Galgiani JN, Bronnimann DA. Coccidioidomycosis during pregnancy - an analysis of ten cases among 47,120 pregnancies. Chest 1988;94:376-9.
25. Powell BL, Drutz DJ, Huppert M, Sun SH. Relationship of progesterone- and estradiol-binding proteins in Coccidioides immitis to coccidioidal dissemination in pregnancy. Infect Immun 1983;40:478-85.
26. H2 phenomenon? Immunol Today 1993;14:353-6.
27. Beaman L, Pappagianis D, Benjamini E. Significance of T-cells in resistance to experimental murine coccidioidomycosis. Infect Immun 1977;17:580-5.
28. Einstein HE, Johnson RH. Coccidioidomycosis: new aspects of epidemiology and therapy. Clin Infect Dis 1993;16:349-54.
29. Jinadu BA. Valley Fever Task Force report on the control of Coccidioides immitis. Bakersfield, CA: Kern Country Health Department, 1995.
30. Pappagianis D. Marked increase in cases of coccidioidomycosis in California: 1991, 1992, and 1993. Clin Infect Dis 1994;19:S14-8.
31. CDC. Update: Coccidioidomycosis - California, 1991-1993. MMWR 1994;43:421-3.
32. Dodge RR, Lebowitz MD, Barbee R, Burrows B. Estimates of C. immitis infection by skin test reactivity in an endemic community. Am J Public Health 1985;75:863-5.
33. Cohen IM, Galgiani JN, Potter D, Ogden DA. Coccidioimomycosis in renal replacement therapy. Arch Intern Med 1982;142:489-94.
34. Rutala PJ, Smith JW. Coccidioidomycosis in potentially compromised hosts: the effect of immunosuppressive therapy in dissemination. Am J Med Sci 1978;275:283-95.
35. Krishnan L, Guilbert LJ, Russell AS, Wegmann TG, Mosmann TR, Belosevic M. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines. J Immunol 1996;156:644-52.
36. Bronnimann DA, Adam RD, Galgiani JN, Habib MP, Peterson EA, Porter B, et al. Coccidioidomycosis in the acquired immunodeficiency syndrome. Ann Intern Med 1987;106:372-9.
37. Fish DG, Ampel NM, Galgiani JN, Dols CL, Kelly PC, Johnson CH, et al. Coccidioidomycosis during human immunodeficiency virus infection-A review of 77 patients. Medicine (Baltimore) 1990;69:384-91.
38. Ampel NM, Dols CL, Galgiani JN. Coccidioidomycosis during human immunodeficiency virus infection: results of a prospective study in a coccidioidal endemic area. Am J Med 1993;94:235-40.
39. Galgiani JN, Catanzaro A, Cloud GA, Higgs J, Friedman BA, Larsen RA, et al. Fluconazole therapy for coccidioidal meningitis: the NIAID - Mycoses Study Group. Ann Intern Med 1993;119:28-35.
40. Tucker RM, Denning DW, Dupont B, Stevens DA. Itraconazole therapy for chronic coccidioidal meningitis. Ann Intern Med 1990;112:108-12.
41. Dewsnup DH, Galgiani JN, Leviner BE, Sharkey-Mathin PK, Fierer J, Stevens DA. Is it ever safe to stop azole therapy for Coccidioides immitis meningitis? Ann Intern Med 1996;124:305-10.
42. Catanzaro A, Fierer J, Friedman PJ. Fluconazole in the treatment of persistent coccidioidomycosis. Chest 1990;97:666-9.
43. Graybill JR, Stevens DA, Galgiani JN, Dismukes WE, Cloud GA, et al. Itraconazole treatment of coccidioidomycosis. Am J Med 1990;89:282-90.
44. Catanzaro A, Galgiani JN, Levine BE, Sharkey-Mathis PK, Fierer J, Stevens DA, et al. Fluconazole in the treatment of chronic pulmonary and nonmeningeal disseminated coccidioidomycosis. NIAID Mycoses Study Group. Am J Med 1995;98:249-56.
45. Levine HB, Cobb JM, Smith CE. Immunogenicity of spherule - endospore vaccines of Coccidioides immitis for mice. J Immunol 1961;87:218-27.
46. Pappagianis D, et al. Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. Am Rev Respir Dis 1993;148:656-60.
47. Huppert M, Spratt NS, Vukovich KR, Sun SH, Rice EH. Antigenic analysis of coccidioidin and spherulin determined by two-dimensional immunoelectrophoresis. Infect Immun 1978;20:541-51.
48. Cox RA, Britt LA. Isolation and identification of an exoantigen specific for Coccidioides immitis. Infect Immun 1986;52:138-43.
49. Cole GT, Kirkland TN, Sun SH. An immunoreactive, water-soluble conidial wall fraction of Coccidioides immitis. Infect Immun 1987;55:657-67.
50. Cole GT, Kirkland TN, Zhu M, Yuan L, Sun SH, Hearn VN. Immunoreactivity of a surface wall fraction produced by spherules of Coccidioides immitis. Infect Immun 1988;56:2695-701.
51. Dugger KO, Galgiani JN, Ampel NM, Sun SH, Magee DM, Harrison J, et al. An immunoreactive apoglycoprotein purified from Coccidioides immitis. Infect Immun 1991;59:2245-51.
52. Galgiani JN, Sun SH, Dugger KO, Ampel NM, Grace GC, Harrison J, et al. An arthroconidial-spherule antigen of Coccidioides immitis: differential expression during in vitro fungal development and evidence for humoral response in humans after infection or vaccination. Infect Immun 1992;60:2627-35.
53. Kirkland TN, Zhu SW, Cruse D, Hsu LL, Seshan KR, Cole GT. Coccidioides immitis fractions which are antigenic for immune T lymphocytes. Infect Immun 1991;59:3952-61.
54. Wycoff E, Pishco J, Kirkland TN, Cole GT. Cloning and expression of a T-cell reactive protein from Coccidioides immitis: homology to 4-hydroxyphenylpyruvate dixygenase and the mammalian F-antigen. Gene 1995;161:107-11.
55. Lecara G, Cox RA, Simpson RB. Coccidioides immitis vaccine: potential of an alkali-soluble, water-soluble cell wall antigen. Infect Immun 1983;39:473-5.